Seven Mile Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-479
Closed -$235K 200
2026
Q1
$235K Sell
479
-296
-38% -$161K 0.17% 143
2025
Q4
$449K Sell
775
-96
-11% -$54.3K 0.08% 123
2025
Q3
$422K Buy
871
+277
+47% +$129K 0.07% 151
2025
Q2
$241K Sell
594
-120
-17% -$50.2K 0.14% 142
2025
Q1
$355K Buy
714
+18
+3% +$9.75K 0.24% 93
2024
Q4
$362K Buy
696
+131
+23% +$72K 0.23% 84
2024
Q3
$349K Buy
565
+32
+6% +$18.9K 0.23% 88
2024
Q2
$294K Buy
533
+35
+7% +$20.1K 0.22% 93
2024
Q1
$289K Buy
498
+35
+8% +$19.6K 0.22% 102
2023
Q4
$246K Buy
+463
New +$224K 0.21% 110

Other funds holding TMO

Seven Mile Advisory's TMO Position: Q2 2026 in Review

Seven Mile Advisory sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 479 shares — an estimated $235K sold.

Seven Mile Advisory first reported a position in TMO in Q4 2023 and held it in 10 quarters. The position peaked at $449K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Seven Mile Advisory reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
  • Seven Mile Advisory sold 479 Thermo Fisher Scientific shares in Q2 2026, an estimated $235K.
  • Seven Mile Advisory first reported a position in Thermo Fisher Scientific in Q4 2023 and held it in 10 quarters.
  • Seven Mile Advisory's Thermo Fisher Scientific position peaked at $449K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.